Anne Langsted Selected Research

Apolipoproteins

1/2022	ApoB and Non-HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk.
12/2020	VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins.
1/2020	Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.
1/2020	Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM.
2/2019	Nonfasting versus fasting lipid profile for cardiovascular risk prediction.
3/2011	Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Langsted Research Topics

Disease

26	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 11/2016
20	Myocardial Infarction 01/2023 - 05/2014
10	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 07/2015
7	Pancreatitis 10/2023 - 07/2016
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 05/2014
6	Atherosclerosis 01/2020 - 07/2016
5	Inflammation (Inflammations) 01/2023 - 05/2014
5	Ischemic Stroke 01/2023 - 01/2019
4	Hypertriglyceridemia 10/2023 - 01/2018
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 11/2022 - 07/2016
3	Diabetes Mellitus 01/2023 - 03/2011
2	Chronic Pancreatitis 01/2023 - 09/2021
2	Cholelithiasis 01/2023 - 12/2016
2	Thrombosis (Thrombus) 01/2022 - 11/2016
2	Hypertension (High Blood Pressure) 01/2019 - 12/2016
1	Hypoglycemia (Reactive Hypoglycemia) 04/2024
1	Peripheral Arterial Disease 01/2023
1	COVID-19 01/2022
1	Heart Failure 01/2022
1	Aortic Valve Disease 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2021
1	Neoplasms (Cancer) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Infections 01/2021
1	Heart Diseases (Heart Disease) 02/2019
1	Hypercholesterolemia 01/2019
1	Stroke (Strokes) 01/2019
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Injection Site Reaction 01/2018
1	Macular Degeneration (Age-Related Maculopathy) 12/2017
1	Type 2 Diabetes Mellitus (MODY) 12/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2017
1	beta-Thalassemia (Cooley's Anemia) 12/2017
1	Hemorrhage 11/2017
1	Leukocytosis (Pleocytosis) 01/2017
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2017
1	Pathologic Constriction (Stenosis) 11/2016
1	Homozygous Familial Hypercholesterolemia 07/2016

Drug/Important Bio-Agent (IBA)

28	Lipoprotein(a)IBA 02/2024 - 05/2014
19	CholesterolIBA 11/2023 - 01/2016
19	LDL CholesterolIBA 01/2023 - 01/2016
15	Triglycerides (Triacylglycerol)IBA 10/2023 - 07/2016
12	LipidsIBA 04/2024 - 03/2011
12	Lipoproteins (Lipoprotein)IBA 11/2023 - 03/2011
7	oxidized low density lipoproteinIBA 01/2023 - 12/2017
7	HDL CholesterolIBA 01/2022 - 01/2018
6	ApolipoproteinsIBA 01/2022 - 03/2011
5	Apolipoproteins B (ApoB)IBA 01/2022 - 01/2018
4	C-Reactive ProteinIBA 01/2023 - 07/2015
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 01/2016
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 12/2016
2	VLDL LipoproteinsIBA 10/2023 - 12/2020
2	Antisense OligonucleotidesIBA 01/2021 - 01/2019
2	PCSK9 InhibitorsIBA 01/2019 - 01/2016
1	AngiopoietinsIBA 10/2023
1	ChylomicronsIBA 10/2023
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 10/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	ProcalcitoninIBA 01/2022
1	eicosapentaenoic acid ethyl esterIBA 12/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2021
1	OilsIBA 12/2021
1	Amylases FDA Link 09/2021
1	VLDL CholesterolIBA 12/2020
1	lipoprotein cholesterolIBA 12/2020
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2019
1	AKCEA-APO(a)-LRxIBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017
1	Apolipoproteins AIBA 11/2016
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2016
1	SubtilisinIBA 01/2016
1	AlbuminsIBA 03/2011

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2017
2	Secondary Prevention 01/2023 - 01/2020
1	Injections 01/2018